NO20016047L - Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav - Google Patents

Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav

Info

Publication number
NO20016047L
NO20016047L NO20016047A NO20016047A NO20016047L NO 20016047 L NO20016047 L NO 20016047L NO 20016047 A NO20016047 A NO 20016047A NO 20016047 A NO20016047 A NO 20016047A NO 20016047 L NO20016047 L NO 20016047L
Authority
NO
Norway
Prior art keywords
isolation
purification
hyaluronidase
manillase
preparation
Prior art date
Application number
NO20016047A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016047D0 (no
Inventor
Maria Kordowicz
Detlef Guessow
Uwe Hofmann
Tedeausz Pacuszka
Andrzej Gardas
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20016047D0 publication Critical patent/NO20016047D0/no
Publication of NO20016047L publication Critical patent/NO20016047L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20016047A 1999-06-12 2001-12-11 Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav NO20016047L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99111468 1999-06-12
PCT/EP2000/005181 WO2000077221A1 (en) 1999-06-12 2000-06-06 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production

Publications (2)

Publication Number Publication Date
NO20016047D0 NO20016047D0 (no) 2001-12-11
NO20016047L true NO20016047L (no) 2001-12-11

Family

ID=8238352

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016047A NO20016047L (no) 1999-06-12 2001-12-11 Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav

Country Status (23)

Country Link
US (1) US7049124B1 (sk)
EP (1) EP1185666B1 (sk)
JP (1) JP2003502045A (sk)
KR (1) KR20020011138A (sk)
CN (1) CN1355850A (sk)
AR (1) AR024335A1 (sk)
AT (1) ATE324452T1 (sk)
AU (1) AU6149300A (sk)
BR (1) BR0011500A (sk)
CA (1) CA2376467A1 (sk)
CZ (1) CZ20014383A3 (sk)
DE (1) DE60027562T2 (sk)
DK (1) DK1185666T3 (sk)
ES (1) ES2258976T3 (sk)
HK (1) HK1046297A1 (sk)
HU (1) HUP0201452A2 (sk)
MX (1) MXPA01012806A (sk)
NO (1) NO20016047L (sk)
PL (1) PL352060A1 (sk)
PT (1) PT1185666E (sk)
SK (1) SK17612001A3 (sk)
WO (1) WO2000077221A1 (sk)
ZA (1) ZA200200233B (sk)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866120A (en) 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
US6610292B2 (en) 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
JP2002506013A (ja) 1998-03-09 2002-02-26 イスタ ファーマシューティカルズ インコーポレイテッド 酵素角膜矯正術における角膜硬化剤の使用
JP2006523461A (ja) * 2003-04-15 2006-10-19 イスタ・ファーマスーティカルズ・インコーポレイテッド 羊ヒアルロニダーゼを単離し精製する方法
AU2003239763A1 (en) * 2003-05-27 2005-01-04 Friedrich-Schiller- Universität Jena Hyaluronate lyase-containing agent for treating acute myocardial infarction or symptoms thereof and for the treatment of postinfarction myocarditis and myocardial ischaemia
WO2005030962A1 (en) * 2003-09-26 2005-04-07 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Synthetic heparanase molecules and uses thereof
RU2471867C2 (ru) * 2007-06-19 2013-01-10 Тамара П. Уваркина Гиалуронидаза и способ ее применения
GB0717166D0 (en) * 2007-09-04 2007-10-17 Univ Brighton Method for stabilisation of purified P-Glycoprotein
EP4269578B1 (en) * 2008-03-06 2024-06-05 Halozyme, Inc. Soluble hyaluronidase composition
EP2177227B1 (en) * 2008-10-14 2013-03-20 Burgard, Gunter, Dr. med. Use of hyaluronidase for the prevention or treatment of arterial hypertension.
CN103889446B (zh) * 2011-10-18 2017-03-08 德国杰特贝林生物制品有限公司 硫酸化糖胺聚糖与透明质酸酶组合用于改善因子viii的生物利用度
EP2698636A1 (en) * 2012-08-13 2014-02-19 Fundació Institut d'Investigació Biomèdica de Bellvitge Methods and reagents for prevention and/or treatment of transplant rejection
US8790711B2 (en) 2012-09-17 2014-07-29 Biopep Solutions, Inc. Treating diabetes with a whole, leech saliva extract
KR101454646B1 (ko) 2012-11-05 2014-10-27 (주)한국비엠아이 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제
CN103060291B (zh) * 2012-12-28 2014-10-08 青岛九龙生物医药有限公司 一种玻璃酸酶的提取方法
CN103695448B (zh) * 2013-07-29 2016-08-17 江南大学 一种透明质酸酶编码基因及其发酵生产和纯化方法
US9279111B2 (en) * 2013-07-29 2016-03-08 Jiangnan University Leech hyaluronidase and its application
CN104263666B (zh) * 2014-09-12 2017-07-14 江南大学 一种产小分子透明质酸的重组毕赤酵母及其构建方法
CN106148302A (zh) * 2016-07-08 2016-11-23 中国人民解放军军事医学科学院生物工程研究所 一种重组蛋白质的纯化方法
CN106520728B (zh) * 2016-11-08 2019-06-21 江南大学 一种提高水蛭透明质酸酶酶活的方法
CN109298113B (zh) * 2018-12-11 2021-06-18 华熙生物科技股份有限公司 一种测定包含有柠檬酸的溶液中的透明质酸含量的方法
WO2021213623A1 (en) * 2020-04-20 2021-10-28 Pharmact Holding Ag A modified bacterial hyaluronidase polypeptide, production process, pharmaceutical compositions and their uses
CN112915106A (zh) * 2021-02-05 2021-06-08 张虎山 一种肿瘤免疫微环境调控剂的制备及其应用
WO2023067008A1 (en) * 2021-10-19 2023-04-27 Pharmact Holding Ag A production of a purified modified bacterial hyaluronidase polypeptide, pharmaceutical compositions and their uses
CN116640745B (zh) * 2023-06-29 2023-12-08 江南大学 透明质酸酶突变体及其在水解硫酸软骨素中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8504025D0 (en) * 1985-02-16 1985-03-20 Biopharm Ltd Hyaluronidase
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
US5747027A (en) 1995-04-07 1998-05-05 The Regents Of The University Of California BH55 hyaluronidase

Also Published As

Publication number Publication date
EP1185666B1 (en) 2006-04-26
BR0011500A (pt) 2002-03-12
NO20016047D0 (no) 2001-12-11
PT1185666E (pt) 2006-09-29
DE60027562T2 (de) 2006-11-02
CA2376467A1 (en) 2000-12-21
MXPA01012806A (es) 2002-09-02
DE60027562D1 (de) 2006-06-01
AU6149300A (en) 2001-01-02
CZ20014383A3 (cs) 2002-03-13
EP1185666A1 (en) 2002-03-13
ES2258976T3 (es) 2006-09-16
CN1355850A (zh) 2002-06-26
DK1185666T3 (da) 2006-07-03
ATE324452T1 (de) 2006-05-15
WO2000077221A1 (en) 2000-12-21
SK17612001A3 (sk) 2002-04-04
KR20020011138A (ko) 2002-02-07
HUP0201452A2 (en) 2002-08-28
JP2003502045A (ja) 2003-01-21
AR024335A1 (es) 2002-10-02
HK1046297A1 (zh) 2003-01-03
ZA200200233B (en) 2003-06-25
PL352060A1 (en) 2003-07-28
US7049124B1 (en) 2006-05-23

Similar Documents

Publication Publication Date Title
NO20016047L (no) Hyaluronidase fra Hirudinaria manillensis, isolering, rensing og rekombinant fremgangsmåte for fremstilling derav
DE69838294D1 (de) Verfahren zur Herstellung von Nukleinsäurekonstrukten
HUP0203409A2 (hu) Gamma-interferon-konjugátumok
NO20012223D0 (no) Nukleotid og proteinsekvenser for NOGO-gener og fremgangsmåter basert derpå
MX9602993A (es) Hormona del crecimiento humano.
WO1998049300A3 (en) Truncated vegf-related proteins
DE69731834D1 (de) Agouti verwandtes gen
ATE338110T1 (de) Verbesserte phytasen
WO2004043407A3 (en) Methods and products for treating staphylococcal infections
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
DK1165759T3 (da) Polypeptider, der har forgrenende enzymaktivitet, og nukleinsyrer, der koder for samme
WO1995006735A3 (en) Nucleotide sequences for novel protein tyrosine phosphatases
WO2003089608A3 (en) Drg11-responsive (dragon) gene family
DE69031803T2 (de) Verfahren und nukleinsäuresequenzen zur expression des zellulose-synthase-operons
NO931400L (no) Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav
DE59510829D1 (de) Gentherapeutisches verfahren unter verwendung von dna-vektoren ohne selektionsmarker-gen
GR3037092T3 (en) Tyrosinase-activator protein fusion enzyme
JPH0257192A (ja) モチリン様ポリペプチドの製法並びにそのための組換えｄｎａ及び発現用プラスミド
HUP0004409A2 (hu) Eljárás az Escherichia coli DSM 6601 törzs azonosítására
AU5023096A (en) Nucleotide and deduced amino acid sequences of tumor gene int6
ATE278011T1 (de) Human dnase ii
WO2003016343A3 (en) USE OF αCP1, αCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING ANGIOGENESIS
WO2002010375A1 (fr) Sequence genique de tete d'origine humaine, vecteur genetique et procede d'expression dudit gene
UA36466A (uk) Спосіб отримання фетальних препаратів
WO1998046742A3 (de) Dictyocaulus viviparus antigen zur diagnose des lungenwurmbefalls und zur vakzinierung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application